Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey

Abstract

Background and objective Non-communicable diseases like systemic arterial hypertension (SAH) and dyslipidemia are poorly studied in terms of patient journey aspects. This semi-systematic review provides evidence synthesis for the management of SAH and dyslipidemia in Brazil and also discusses challenges faced by patients at the local level along with a suggested care approach by local experts. Methods A semi-systematic review using both structured literature databases (Embase and Medline) and unstructured scientific records (WHO, IPD, MOH and Google) on hypertension and dyslipidemia in the English language from 2010 to 2019 was performed by reviewers. After two-level screening based on pre-defined criteria, patient journey touchpoints and prevalence information were extracted from the included articles. Data gaps were bridged through the insights of local experts. Results Prevalence of hypertension and dyslipidemia in Brazil were 23% and 40.8%, respectively. Awareness of dyslipidemia was found in a larger proportion (58.1%) than in SAH (22.2%). Similarly, screening for hypertension (97%) and dyslipidemia (55.4%) were found to be effective, while treatment was (62.9%) and (30.0%) for hypertension and dyslipidemia, respectively. Conclusion There were important gaps on patient awareness and treatment of dyslipidemia and hypertension. Limited patient education, regional disease distribution, and treatment allocation, along with limited resources for diagnosis and treatment are the key challenges.

Assessing statins use in a real-world primary care digital strategy: a cross-sectional analysis of a population-wide digital health approach

“…Statins are recommended by guidelines to intensively reduce LDL-cholesterol in people with previous manifestations of ASCVD however previous studies had shown that recommended LDL-cholesterol goals were seldom attained by Brazilian patients. 6 , 15 , 16 , 23 , 24 The findings of this study performed in a broad sample of patients from different Brazilian regions visited by CHW in both rural and urban areas, indicate that absence or inadequate statin use may explain the latter. In addition, subjects reported low use of combination therapy with ezetimibe and no use of PCSK9 inhibitors, medications that reduce not only LDL-cholesterol but prevent ASCVD events.…”

Trends in exercise for hypertension: a bibliometric analysis

“…Brazil ranks first in the number of articles published on this topic. This may be associated with the high incidence of hypertension in the country and the low cost of exercise treatment ( 25 ). China follows closely in third place, which may also be credited to the high incidence of hypertension and the popularity of traditional Chinese practices such as Baduan Jin and Tai Chi ( 26 , 27 ).…”

Patient journey for hypertension and dyslipidemia in Saudi Arabia: highlighting the evidence gaps

“…The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used in this review, with minor modifications to fit within the scope of this study. The evidence was mapped using MAPS (Mapping the Patient Journey Towards Actionable Beyond the Pill Solutions) methodological approach [ 18 , 21 ]. The mapping strategy was divided into six steps: (1) developing a comprehensive search strategy; (2) establishing the inclusion and exclusion criteria; (3) screening and shortlisting; (4) supplementing with additional and/or local data; (5) data extraction and synthesis; and (6) evidence mapping.…”

“…Previously, a national survey that mapped patient journeys in the Saudi population in 2005 reported > 1200 participants to be hypertensive with less than half of them being aware, receiving treatment, and having their BP controlled [ 17 ]. However, the studies reporting patient journeys in the following years were region-specific individual studies done at different times [ 18 ]. This may not provide an accurate estimate across all the journey touchpoints within the Saudi population who already have varied cultural norms and behavior towards CVD management [ 19 ].…”